Muscular Dystrophy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Recessive mutations in the anoctamin-5-encoding gene (ANO5) cause muscular dystrophy of various phenotypes.
|
30320887 |
2019 |
Muscular Dystrophy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Development of muscular dystrophy in a CRISPR-engineered mutant rabbit model with frame-disrupting ANO5 mutations.
|
29789544 |
2018 |
Muscular Dystrophy
|
0.400 |
Biomarker
|
disease |
BEFREE |
Diagnostic anoctamin-5 protein defect in patients with ANO5-mutated muscular dystrophy.
|
28489263 |
2018 |
Muscular Dystrophy
|
0.400 |
Biomarker
|
disease |
BEFREE |
Limb girdle muscular dystrophy type 2L (LGMD2L) is an adult-onset slowly progressive muscular dystrophy associated with anoctamin 5 (ANO5) gene mutation, mainly reported from Northern and Central Europe.
|
28214267 |
2017 |
Muscular Dystrophy
|
0.400 |
Biomarker
|
disease |
MGD |
The phenotypic overlap of ANO5 myopathies with dysferlin-associated muscular dystrophies has inspired the hypothesis that ANO5, like dysferlin, may be involved in the repair of muscle membranes following injury.
|
26911675 |
2016 |
Muscular Dystrophy
|
0.400 |
Biomarker
|
disease |
BEFREE |
The phenotypic overlap of ANO5 myopathies with dysferlin-associated muscular dystrophies has inspired the hypothesis that ANO5, like dysferlin, may be involved in the repair of muscle membranes following injury.
|
26911675 |
2016 |
Muscular Dystrophy
|
0.400 |
GeneticVariation
|
disease |
CLINVAR |
Next generation sequencing on patients with LGMD and nonspecific myopathies: Findings associated with ANO5 mutations.
|
25891276 |
2015 |
Muscular Dystrophy
|
0.400 |
Biomarker
|
disease |
BEFREE |
Comparing clinical data and muscle imaging of DYSF and ANO5 related muscular dystrophies.
|
25176504 |
2014 |
Muscular Dystrophy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
So far, no case with a silent mutation leading to abnormal splicing has been identified in Anoctamin 5 muscular dystrophy.
|
24239059 |
2014 |
Muscular Dystrophy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
As ANO5 has also been found to be mutated in two different forms of muscular dystrophy, the finding of this third mutation in GDD adds clues to the role of ANO5 in these disorders.
|
23047743 |
2013 |
Muscular Dystrophy
|
0.400 |
Biomarker
|
disease |
BEFREE |
This study reports the phenotype and genotype of seven unrelated patients with ANO5-muscular dystrophy.
|
23663589 |
2013 |
Muscular Dystrophy
|
0.400 |
Biomarker
|
disease |
BEFREE |
Anoctamin 5 muscular dystrophy in Denmark: prevalence, genotypes, phenotypes, cardiac findings, and muscle protein expression.
|
23670307 |
2013 |
Muscular Dystrophy
|
0.400 |
Biomarker
|
disease |
BEFREE |
This finding suggests that patients with amyloid in muscle should be screened for anoctamin 5 muscular dystrophy.
|
21820307 |
2012 |
Muscular Dystrophy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Mutations in ANO5 are a frequent cause of undetermined muscular dystrophy, with both distal and proximal presentation.
|
22402862 |
2012 |
Muscular Dystrophy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Limb girdle muscular dystrophy type 2L (LGMD2L) is an adult-onset slowly progressive muscular dystrophy associated with recessive mutations in the ANO5 gene.
|
22980763 |
2012 |
Muscular Dystrophy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
The cases reported here should help to better understand the important role of mutation screening in the ANO5 gene in patients with adult onset muscular dystrophy and very high CK levels.
|
22499103 |
2012 |
Muscular Dystrophy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
The excitement about Tmem16 proteins has been enhanced by the finding that Ano1 has been linked to cancer, mutations in Ano5 are linked to several forms of muscular dystrophy (LGMDL2 and MMD-3), mutations in Ano10 are linked to autosomal recessive spinocerebellar ataxia, and mutations in Ano6 are linked to Scott syndrome, a rare bleeding disorder.
|
21642943 |
2011 |
Muscular Dystrophy
|
0.400 |
Biomarker
|
disease |
BEFREE |
We have further defined the clinical phenotype of ANO5-associated muscular dystrophy.
|
21186264 |
2011 |
Muscular Dystrophy
|
0.400 |
Biomarker
|
disease |
BEFREE |
Though the function of the ANO5 protein is still unknown, its putative calcium-activated chloride channel function may lead to important insights into the role of deficient skeletal muscle membrane repair in muscular dystrophies.
|
20096397 |
2010 |
Muscular Dystrophy
|
0.400 |
Biomarker
|
disease |
HPO |
|
|
|